Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Ethos Spa and Laser Center Now Offers FDA-Approved Juvederm and Juvederm Voluma XC™ for Non-surgical “Liquid Facelift”
  • USA - English


News provided by

Ethos Spa and Laser Skin Centers

Apr 29, 2014, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Juvederm.  15 minutes for treatment;                             Immediate results.
Juvederm. 15 minutes for treatment; Immediate results.

SUMMIT, N.J. (PRWEB) April 29, 2014 -- Hardik Soni, M.D., Medical Director of Ethos Spa Skin and Laser Centers, now offers both JUVÉDERM® and JUVÉDERM VOLUMA™ XC from Allergan, Inc. to his growing list of cutting-edge anti-aging treatments. JUVÉDERM replaces traditional wrinkle fillers by adding volume to tissue-depleted facial areas, smoothing and softening deep creases for a youthful appearance.
JUVÉDERM is hyaluronic acid gel filler that gives the patient a younger, rejuvenated appearance. Hyaluronic acid is a naturally occurring sugar found in the body that retains water, delivers nutrients, acts as a cushioning agent for the skin, and enhances skin elasticity. JUVÉDERM is available in three formulas, each targeting a different layer of the skin.

JUVÉDERM targets wrinkles, folds and depressions of the face, and augments features like cheeks, brows and the jawline. JUVÉDERM also gives the face s slight “lift”, a more relaxed appearance, and a youthful glow. Soni says that JUVÉDERM is one of the best fillers available for lip enhancement, and for smoothing the fine lines above and below the lips. Results can last six months or longer.

JUVÉDERM VOLUMA XC is the first and only filler approved to temporarily correct age-related volume loss in the cheek area, while diminishing moderate to severe wrinkles and folds.

JUVÉDERM VOLUMA XC helps create a more youthful facial appearance by providing natural-looking, long-lasting (up to two years) fullness in areas of the face that have lost volume and elasticity over time. Volume loss in the cheek area is a natural occurrence in the aging process that causes the facial skin to sag or droop. According to Soni, JUVÉDERM VOLUMA XC can reverse this process by replenishing lost fullness.

JUVÉDERM VOLUMA XC is a non-surgical treatment in which the smooth JUVÉDERM VOLUMA gel is injected into the cheek area to gently lift the skin and restore fullness. JUVÉDERM VOLUMA XC is made with Allergan’s Vyrcross technology, an advanced process that results in a smooth gel that flows easily and consistently for a natural appearance.

JUVÉDERM VOLUMA XC differs from other dermal fillers in that it adds fullness to sunken areas of the face and is longer-lasting, with results lasting up to two years after just one treatment.

“VOLUMA is a great product for addressing volume loss in the face, because the results are so natural and last so long,” Soni says. “So many patients are already benefitting from the volumizing qualities of this product.”

For more information on JUVÉDERM, JUVÉDERM VOLUMA XC or any of the expert aesthetic services available at the Ethos Spa, Skin and Laser Center, visit the Ethos Spa website, call the Summit location at (908) 273-5400, or call the Englewood location at (201) 541-6600.

About Hardik Soni, M.D. and Ethos Spa, Skin and Laser Center:

Ethos Spa, Skin and Laser Center Medical Director Hardik Soni, M.D. strives to achieve the best possible results for his patients by drawing on his experience and proficiency with multiple laser platforms, earned from having performed more than 15,000 cosmetic treatments including botulinum injection (Botox and Dysport), dermal fillers JUVÉDERM, Restylane, Radiesse), laser hair removal, chemical peels and laser skin rejuvenation. He is a platinum level injector with Allergan, the makers of Botox and JUVÉDERM; his primary focus is on minimally invasive and non-invasive cosmetic procedures including Aesthera Candela, Cutera, Fraxel, Sciton and Syneron. Soni believes in a more conservative approach to cosmetic procedures, and prioritizes patient education. Clients are able to decide on their own ideal treatment after discussing their options, and weighing the expected outcomes, costs and risks.

He finished his undergraduate studies at Johns Hopkins University in Baltimore, Maryland and is board certified in Emergency Medicine. Soni currently works as an emergency room physician at Overlook Medical Center in Summit, New Jersey, as well as serving as medical director of Ethos Spa, Skin and Laser Center. He was recently chosen to the Advisory Medical Panel of Bella Magazine in New York City.

Ethos Spa, Skin and Laser Center is committed to providing the safest, most effective aesthetic procedures, customized to each individual client, utilizing the latest advances in non-invasive cosmetic treatments and technologies. Within a peaceful, luxurious environment, patients can choose from a wide array of cosmetic services and products to enhance the skin’s appearance.

Hardik Soni, Ethos Spa and Laser Skin Centers, http://www.ethosspa.com, +1 908-273-5400, [email protected]

Modal title

Juviderm, before and after treatment
Juviderm, before and after treatment
Juvederm Voluma XC
Juvederm Voluma XC
Ethos Spa and Laser Center
Ethos Spa and Laser Center
Juviderm, before and after treatment Juvederm Voluma XC Ethos Spa and Laser Center

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.